RECRUITING

Health and Resilience Projects: Foundations

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Health and Resilience Project (HARP): Foundations is investigating the efficacy of the Strong African American Families (SAAF) intervention in promoting the health and well being of African American adolescents. Youth age 10-13 and their primary caregivers are randomly assigned to receive SAAF or to a control group. Participants complete baseline and follow-up measures regarding vulnerability to substance use based on a neuroimmune model of stress coping.

Official Title

Can Family-Centered Prevention Programming Reduce Neuroimmune Vulnerabilities for Drug Use and Cardiometabolic Risk Among African American Adolescents? A Randomized Prevention Trial

Quick Facts

Study Start:2022-01-25

Study Completion:2027-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05253235

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:10 Years to 13 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:CHILD

Inclusion Criteria	Exclusion Criteria
* Self reported African American or Black; * Age 10-13 * Primary caregiver for youth, * Resides in same household as youth.	* Contraindications for MRI scanning (e.g., metal in body, traumatic brain injury, claustrophobia, pregnancy), * Youth with chronic illnesses or medication regimens that would affect inflammatory panels (e.g., diabetes, congenital heart disease, asthma, cancers). * Conditions (e.g., severe disability, psychoses) that would prevent participation in the SAAF intervention or completing self-report measures.

Inclusion Criteria

Exclusion Criteria

* Self reported African American or Black;
* Age 10-13
* Primary caregiver for youth,
* Resides in same household as youth.

* Contraindications for MRI scanning (e.g., metal in body, traumatic brain injury, claustrophobia, pregnancy),
* Youth with chronic illnesses or medication regimens that would affect inflammatory panels (e.g., diabetes, congenital heart disease, asthma, cancers).
* Conditions (e.g., severe disability, psychoses) that would prevent participation in the SAAF intervention or completing self-report measures.

Contacts and Locations

Study Contact

Heather Zuercher, MPH

CONTACT

706-425-2992

zuercher@uga.edu

Cara Hodge, BS

CONTACT

706-425-2992

thodge@uga.edu

Principal Investigator

Gene H Brody, Ph.D.

PRINCIPAL_INVESTIGATOR

University of Georgia

Study Locations (Sites)

Center for Family Research

Athens, Georgia, 30602

United States

Collaborators and Investigators

Sponsor: University of Georgia

Gene H Brody, Ph.D., PRINCIPAL_INVESTIGATOR, University of Georgia

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-25

Study Completion Date2027-12-31

Study Record Updates

Study Start Date2022-01-25

Study Completion Date2027-12-31

Terms related to this study

Additional Relevant MeSH Terms

Substance Use